Marketed paracetamol

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

22 competitors in Chickenpox

#DrugCompanyPhaseTrials

1

Zovirax

BBp Consulting, Inc

Approved

—2

Hepatitis a Vaccine

Sanofi

Phase 3

53

Zostavax

Merck & Co.

Phase 3

14

Investigational Cancer Drug

GSK

Phase 3

55

Varilrix

GSK

Phase 3

16

MMR-Vaccine

GSK

Phase 3

37

Comparator TIV

Novartis

Phase 3

18

Candidate Varicella Vaccine

GSK

Phase 3

19

PCV 20

GSK

Phase 3

410

Vaxneuvance

GSK

Phase 3

4Show 9 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

Chickenpox5 trials

A Study on the Safety of an Investigational Chickenpox Vaccine, When Given to Healthy Children, 12 to 15 Months of Age

Recruiting·GSK·Phase 3·NCT06693895·750 enrolled

A Study on the Immune Response and Safety of a Combined Measles, Mumps, Rubella, Chickenpox Vaccine Compared to a Marketed Combined Vaccine, Given to Healthy Children 4 to 6 Years of Age

Completed·GSK·Phase 2·NCT05630846·801 enrolled

A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age

Recruiting·GSK·Phase 3·NCT06740630·1,840 enrolled

Show 2 more trials

A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rubella Vaccine When Administered as Intramuscular Injection to Healthy Children 12 to 15 Months of Age

Recruiting·GSK·Phase 3·NCT06855160·900 enrolled

A Study on the Immune Response and Safety of the Second Dose of an Investigational Chickenpox Vaccine When Given to Healthy Children 3 Months After a First Dose at 12 to 15 Months of Age

Recruiting·GSK·Phase 3·NCT06806137·600 enrolled

MPA3 trials

A Study to Compare Two Paracetamol Tablets

Withdrawn·GSK·Phase 1·NCT01381640

A Study to Compare to the Pharmacokinetic Profile of Two Paracetamol Formulations

Completed·GSK·Phase 1·NCT01476189·28 enrolled

A Study to Compare Two Paracetamol Formulations.

Completed·GSK·Phase 1·NCT01592227·30 enrolled

Absorption2 trials

Pharmacokinetic Study Investigating the Extent of Paracetamol Absorption From a New Formulation of Paracetamol Compared With Panadol® Extend

Completed·GSK·Phase 1·NCT01540721·28 enrolled

Pharmacokinetic Study Investigating the Extent of Paracetamol Absorption From a New Formulation of Paracetamol Compared With Panadol®

Completed·GSK·Phase 1·NCT01540734·28 enrolled

Scopolamine1 trial

A Comparative Bioavailability and Adhesion Performance Study, Comparing a New Scopolamine Transdermal Delivery System Formulation to the Currently Established Reference Transdermal Delivery System in Healthy Adult Participants.

Completed·GSK·Phase 1·NCT02839135·128 enrolled

Details

Drug Info

Related News